Vaylen vs LTTL: Compounded GLP-1 price, format, and policies
Quick verdict: Vaylen targets cash-pay shoppers wanting the lowest effective monthly rate with prepaid 12-month plans and a clinician review within 24 hours; LTTL emphasizes pharmacy verification and an introductory discount. Vaylen is best for buyers who accept prepaying a year for lower headline pricing.
Vaylen vs LTTL at a glance
Both providers offer compounded GLP-1 medications and state that compounded medications are not FDA-approved. The most distinctive differences are upfront pricing model and discounts, available medication formats, clinician review and refund policy, and pharmacy verification and lab testing claims.
Headlines compared
| Criteria | Vaylen | LTTL |
|---|---|---|
| Starting price | $83.25/mo semaglutide on 12-month plan | Starting price evidence not published; site shows reference rates up to $249 |
| Discounts or offers | Prepaid 12-month rates billed upfront; full refund if clinician declines | Up to $140 off your first month, code auto-applied |
| Medication formats | Compounded semaglutide injections, oral semaglutide tablets, and tirzepatide | Compounded GLP-1 formulations; full-dose GLP-1 claims |
| Clinician review and timing | Clinician review within 24 hours; you pay before review | Clinician-reviewed online treatment; details subject to live offer |
| Pharmacy and testing | Compounded medications prepared by licensed U.S. pharmacies (Vaylen notes compounding status) | Compounded by U.S. licensed pharmacies; prepared and independently verified in FDA registered labs |
Pricing and payment model: prepaid lowest-rate focus vs first-month discount
Vaylen publishes headline annualized prices that require prepaying a 12-month plan in one charge. Semaglutide injections are $83.25 per month on the 12-month program or $224 per month month to month, oral semaglutide is $99 per month on the 12-month program or $249 monthly, and tirzepatide injections are $149 per month on the 12-month program or $299 monthly. Vaylen states you pay before a clinician reviews your file but that you receive a full refund for that billing cycle if the clinician decides treatment is not appropriate. LTTL’s captured pages advertise up to $140 off the first month with a code auto-applied, and other specific current pricing details were not published or could not be verified on the captured landing page.
Check LTTL offer and first-month code
Medication formats and formulation claims
Vaylen offers three formats on one platform: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide injections. Vaylen highlights that every headline rate is an annualized price on a 12-month plan and that oral semaglutide is the same active ingredient delivered orally, with the tablet costing about $16 per month more than the injectable for the same molecule on the prepaid plan. LTTL markets compounded GLP-1 medications formulated to help regulate appetite and promote fullness and states full-dose GLP-1 is delivered; specific product-by-product format and pricing details were not published in the captured evidence.
Compare Vaylen medication formats
Clinician review, refunds, and verification
Vaylen is explicit that a board-certified U.S. clinician reviews submitted health information within 24 hours and that the company issues a full refund for that billing cycle if a clinician declines to prescribe. Vaylen also notes licensed U.S. clinicians via OpenLoop Health and LegitScript certification. LTTL notes clinician-reviewed online treatment and states medications are prepared in state-licensed pharmacies and independently verified in FDA registered labs, with potency confirmed every 3 to 6 months to stay within ±10 percent of target strength. LTTL captured pages include a note that pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Regulatory note and what is not supplied
Both providers include the regulatory disclosure that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. LTTL’s captured landing-page evidence did not publish expanded FAQ answers or full current terms for renewal and state availability in the captured material. Vaylen publishes details about refund if not approved and the requirement to prepay a full 12-month rate, while LTTL captures emphasize pharmacy verification and a first-month discount.
Quick comparison summary
- Vaylen: lower headline monthly rates on prepaid 12-month plans, three GLP-1 formats, clinician review within 24 hours, full refund if clinician declines.
- LTTL: pharmacy verification and independent lab testing claims, up to $140 off first month code, site captured with fewer published pricing details.
View LTTL lab verification and offer
Final guidance: Choose based on price model and verification priorities
Choose Vaylen if you are a decisive cash-pay buyer who accepts compounded GLP-1, wants the lowest effective monthly rate via prepaid 12-month plans, values a clinician review within 24 hours, and prefers a published full-refund-if-not-approved policy. Choose LTTL if you prioritize pharmacy preparation claims and independent lab verification and want to use a first-month discount or confirm live offer terms, pricing, renewal and state coverage before enrollment. Both note that compounded medications are not FDA-approved, and both require a clinician to determine medical appropriateness.